The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Clinical Implications of Basic Research
PreviousPrevious
Volume 339:472-474 August 13, 1998 Number 7
NextNext

Vascular Targeting as a Strategy for Cancer Therapy

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
New molecular techniques have yielded a battery of potential therapies for many diseases, but the clinical fruits of these methods have not been abundant, in part because in vitro models used for screening often do not duplicate in vivo conditions. For example, in vivo the microvascular wall prevents many intravenous agents with in vitro activity from reaching target cells in the tissue. Moreover, the magic bullet of cancer immunotherapy — antibodies conjugated to a drug or toxin — do not consistently hit their mark, because the bull's-eye on the other side of the vascular endothelium remains largely inaccessible to the . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.